Tompkins Financial
TMP
94.90
-1.16
-1.21%
Tompkins Financial
US · TMP
#3024 by market cap
Listed 1970
94.90
-1.16
-1.21%
Periodic snapshot; not a real-time feed.
· 2026-11-20 16:15
Recent news
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Maintains Target Price $78\u5e02\u573a\u8d44\u8baf · 2025/7/28
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $87\u5e02\u573a\u8d44\u8baf · 2026/2/4
-
Rating change
Piper Sandler Upgrades Tompkins Financial(TMP.US) to Buy Rating, Raises Target Price to $74\u5e02\u573a\u8d44\u8baf · 2025/12/3
-
Company notice
Sosei Group: Our partner Tempero Bio has received approval from FDA for TMP-301 clinical trials for alcohol and other substance use disorders.JPX · 2023/1/5
-
Company notice
Sosei Group: Sosei Notes Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use DisordersJPX · 2023/1/5
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $83\u5e02\u573a\u8d44\u8baf · 2025/2/3
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Maintains Target Price $83\u5e02\u573a\u8d44\u8baf · 2025/4/29
-
Earnings Flash (TMP) Tompkins Financial Corporation Reports Q2 Revenue $87.1M, Vs. FactSet Est of $86.9MMT Newswires · 2026/7/24
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Maintains Target Price $80\u5e02\u573a\u8d44\u8baf · 2025/11/4
-
Company notice
Maoshuo Power: Announcement on Passing UL WTDP and UL CB TMP Laboratory AccreditationSZSI · 2013/7/22
-
Company notice
Nxera Pharma: Our partner Tempero Bio has begun phase 2 testing of TMP-301 targeting alcoholismJPX · 2025/3/25
-
Rating change
Piper Sandler Maintains Tompkins Financial(TMP.US) With Hold Rating, Raises Target Price to $87\u5e02\u573a\u8d44\u8baf · 2026/4/28
-
Piper Sandler Maintains Tompkins Financial(TMP.US) With Hold Rating, Raises Target Price to $104\u5e02\u573a\u8d44\u8baf · 2026/8/3
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $90\u5e02\u573a\u8d44\u8baf · 2026/4/28
-
Earnings Flash (TMP) Tompkins Financial Posts Q2 EPS $2.04, Vs. FactSet Est of $1.82MT Newswires · 2026/7/24
-
Company notice
Nxera Pharma: Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use DisorderJPX · 2025/3/25
-
Rating change
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Cuts Target Price to $78\u5e02\u573a\u8d44\u8baf · 2025/5/2
-
Rating change
Piper Sandler Maintains Tompkins Financial(TMP.US) With Hold Rating, Cuts Target Price to $67\u5e02\u573a\u8d44\u8baf · 2025/5/1
-
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $105\u5e02\u573a\u8d44\u8baf · 2026/7/27
-
KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $107\u5e02\u573a\u8d44\u8baf · 2026/10/26
-
Baichuan Co., Ltd. (002455.SZ): TMP products are primarily used in UV-curable coatings, synthetic lubricants, plasticizers, surfactants, and other applications.Gelonghui Finance · 2026/7/3
-
Rating change
KBW Initiates Tompkins Financial(TMP.US) With Buy Rating, Announces Target Price $68\u5e02\u573a\u8d44\u8baf · 2024/10/2
-
Rating change
Piper Sandler Initiates Tompkins Financial(TMP.US) With Hold Rating, Announces Target Price $70\u5e02\u573a\u8d44\u8baf · 2024/12/21
-
Rating change
Keefe, Bruyette & Woods: Reiterates Tompkins Finl (TMP.US) rating, adjusted from market to market unanimous rating, target price adjusted from $55.00 to $50.00.Zhitong Finance · 2024/5/3
-
Baichuan Co., Ltd. (002455.SZ): The company's TMP capacity is 70,000 tons per year.Gelonghui Finance · 2026/6/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 16:15:00 · For reference only, not investment advice and not tailored to your situation.
Tompkins Financial discussion 0 comments